Global Digital Pathology Systems Strategic Business Report 2018 - Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
DUBLIN, July 5, 2018 /PRNewswire/ --
The "Digital Pathology Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Digital Pathology Systems in US$ Thousand.
The report profiles 55 companies including many key and niche players such as:
-- 3DHISTECH Ltd. (Hungary) -- Apollo Enterprise Imaging Corp. (USA) -- Carl Zeiss AG (Germany) -- Corista LLC (USA) -- Definiens AG (Germany) -- Hamamatsu Photonics K.K. (Japan) -- Huron Digital Pathology, Inc. (Canada) -- Leica Biosystems Nussloch GmbH (Germany) -- MikroScan Technologies, Inc. (USA) -- Olympus Corporation (Japan) -- Philips Healthcare (Netherlands) -- Pixcelldata Ltd. (Ireland) -- Ventana Medical Systems, Inc. (USA) -- VMscope GmbH (Germany)
Key Topics Covered
1. INDUSTRY OVERVIEW
-- Digital Pathology Systems: Providing Accuracy, Efficient Analysis, and Cost Reduction Benefits to Pathology Practices -- Need to Enhance Workflow Efficiencies and Reduce Costs to Aid Growth of Digital Pathology Systems Market -- Developed Markets to Maintain Dominance -- Digital Pathology Systems See Fast Paced Growth in Emerging Nations -- Scanners Lead Digital Pathology Market, Image Analysis Software to Record Fast Growth -- FDA Approval for WSI System Opens Up a World of Opportunities for Digital Pathology Market -- Innovative Software Solutions for Digital Pathology Systems -- Virtual Microscopy -- Digitization of Microscopic Slides to Drive Growth -- Disease Diagnosis -- The Major Application of Digital Pathology Systems -- Hospitals and Laboratories Dominate Digital Pathology Systems Market -- Major Issues Hampering Adoption of Digital Pathology Systems -- Technology Related Challenges Hold Back Adoption of Digital Pathology Systems -- The Future in Retrospect
2. COMPETITIVE LANDSCAPE
-- A Competitive Marketplace -- Leica Dominates the Market -- Philips' IntelliSite Pathology System -- An Advanced Digital Pathology Solution
3. MARKET DRIVERS, TRENDS & ISSUES
-- The Many Advantages of Digital Pathology over Traditional Pathology -- The Invaluable Connected Data Made Possible by Digital Pathology Systems -- The Need for Automation in Tissue Analysis -- Workflow Efficiencies: A Key Market Driver for Digital Pathology Systems -- Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems -- Need for Early Diagnosis Puts Focus on Digital Pathology -- Clinical Research Continues to be Core Vertical for Digital Pathology -- Digital Pathology Evolves to Computational Pathology -- Computational Pathology for Leading-Edge Image Analytics -- Technological Advancements Ease Issues in Digital Pathology Adoption -- Possibilities Ahead in Digital Pathology -- Digital Pathology Systems Continue to Widen their Scope -- Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases -- Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses -- Move towards Hosted Technology: The New Fad -- Digital Pathology as a Service Eludes Cost-based Issues -- Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations -- Rising Emphasis on Lab Automation Extends Opportunity for Digital Pathology -- Rising Penetration of Personalized Medicine Bodes Well for Digital Pathology -- Increased Focus on Companion Diagnostics to Benefit the Market -- Digital Pathology Images and the Quality Concerns -- Improving Healthcare & Research Expenditures Turbo Charge Digital Pathology -- Burgeoning Global Population: A Strong Business Case for Market Growth -- Aging Population: A Key Opportunity Indicator -- Challenges Facing Digital Pathology Systems Market -- High Costs -- Workflow Integration with Other Related Functions -- Other Issues
4. PRODUCT OVERVIEW
5. PRODUCT INTRODUCTIONS/INNOVATIONS
-- Inspirata and Lab Information System Create Bi-Direction Interface -- Applied Spectral Imaging Introduces PathFusion and HiPathPro for Digital Pathology -- OptraSCAN Unveils Frozen Sections Whole Slide Imaging Scanner -- OptraSCAN Introduces On-Demand Digital Pathology System -- Proscia Launches New Product for Digital Clinical Workflows in Anatomic Path Labs -- microDimensions Launches Anyslide Cloud-based Digital Pathology Platform -- Proscia Launches New Software as a Lab Concept -- Philips Gains FDA Approval for First Digital pathology Whole Slide Imaging System -- Leica Demonstrates Aperio VERSA Digital Pathology System -- PerkinElmer Introduces Vectra Polaris Automated Quantitative Pathology Imaging System -- OptraSCAN Introduces On-Demand Image Analysis Suite -- Philips Launches New Digital Pathology and Computational Pathology Solutions -- Huron Updates TissueScope Whole Slide Imaging Platform -- OptraSCAN Introduces Fluorescent Whole Slide Imaging Scanner -- ViewsIQ Unveils Panoptiq Digital Slide Imaging Platform -- Definiens Introduces VeriTrova for Supporting Translational and Biomarker Research of Takeda -- Proscia Launches New Image Analysis Applications for Cancer Research -- Sheffield and Hull NHS Hospitals Develop Novel Digital Pathology Network -- OptraSCAN Introduces 120-slide Whole Slide Imaging Scanner -- TRIBVN Unveils CaloPix 3.1.2 Software -- Pathcore Introduces Pathcore Web -- Optra Systems Unveils Subscription-based On-Demand Digital Pathology System -- microDimensions Introduces Upgrade for Digital Pathology Viewer -- Clearpath Unveils Clearpath 3.0 for Dermatopathology -- Omnyx Rolls Out Dynamyx Digital Pathology Software -- Visiopharm Launches New VIS 6.0 Version -- PerkinElmer Unveils Vectra 3 System for Quantitative Pathology Imaging Research -- Leica Launches New Aperio Digital Pathology Products -- Objective Pathology Launches MyObjective Digital Pathology Image Management Server -- Leica Introduces Aperio LV1 Digital Pathology System for Telepathology -- Glencoe Software Introduces PathViewer for Digital Pathology -- Leica Launches VERSA Digital Pathology Research Scanner -- Sectra Launches New Solution for Digital Pathology Images -- Proscia Launches Cloud-Based Digital Pathology Software Platform -- Inspirata Unveils New Solutions for Digital Pathology -- Huron Unveils New Whole Slide Scanners
6. RECENT INDUSTRY ACTIVITY
-- Inspirata Inks Agreement with Leica Biosystems to Expand Digital Pathology Scanners Portfolio -- Inspirata and Elsevier Collaborate -- Neagen and Visiopharm Announce Integration of PACS and Image Analysis -- Philips Transforms Austrian Labs with IntelliSite Pathology Solution -- OptraSCAN Enters into Agreement with Kansas Pathology Consultants -- Vsternorrland County Council Selects Sectra's Digital Pathology Solution -- Leica and Kuwait Ministry of Health Enter into Partnership -- TRIBVN, Hamamatsu and CHUM Partner for Centre of Excellence in Digital Pathology -- Philips Collaborates with PathAI -- Corista and Elsevier Collaborate for Improving Digital Pathology Workflow -- Proscia and Huron Enter into Partnership for Integrated Digital Pathology Scanner-Software Solution -- Leica Enters into Strategic Partnership with Leeds Teaching Hospitals -- ADS Biotec and ViewsIQ in Strategic Partnership for Pathology Software -- Opta-Tech to Distribute Sectra's Digital Pathology Solution in Poland -- Visiopharm Takes Over LRI Imaging -- Pathcore and Visiopharm in Partnership for Digital Pathology Solution -- Sectra Enters into Agreement with Visiopharm -- Mikroscan and QualityStar Forge Partnership -- Inspirata Takes Over Precision Medicine Network -- Leica Integrates CEREBRO System with Psyche's Products -- Philips and Visiopharm Ink Licensing Agreement -- Philips Takes Over PathXL -- Leica Collaborates with UCLA for Digital Pathology -- ISENET Inks Global Distribution Agreement with Visiopharm -- Mikroscan and XIFIN Enter into Partnership -- Roche Acquires Leeds Virtual Microscope Technology -- Omnyx Gains FDA Approval for Creation of Digital Pathology System -- Sectra Takes Over RxEye -- NantOmics Concludes Round A Financing for OptraSCAN -- Path Links Upgrades to Digital pathology Network -- Ensigna Acquires TISSUEScope LE from Huron -- Philips Collaborates with Genomic Health for Digital Pathology -- Inspirata Inks Reseller and Integration Agreement with mTuitive -- Philips and Mount Sinai Health System Enter into Agreement Digital pathology Repository -- Philips and Inspirata Enter into Joint Development Agreement -- Omnyx Inks MoU with Argent Global Services -- CliniSys Partners with Mawell -- SeongKohn and Pixcelldata Partner to Introduce Digital Pathology Software in Korea -- Huron Rebrands into Huron Digital Pathology
7. FOCUS ON SELECT PLAYERS
-- 3DHISTECH Ltd. (Hungary) -- Apollo Enterprise Imaging Corp. (USA) -- Carl Zeiss AG (Germany) -- Corista LLC (USA) -- Definiens AG (Germany) -- Hamamatsu Photonics K.K. (Japan) -- Huron Digital Pathology, Inc. (Canada) -- Leica Biosystems Nussloch GmbH (Germany) -- MikroScan Technologies, Inc. (USA) -- Olympus Corporation (Japan) -- Philips Healthcare (Netherlands) -- Pixcelldata Ltd. (Ireland) -- Ventana Medical Systems, Inc. (USA) -- VMscope GmbH (Germany)
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 55 (including Divisions/Subsidiaries 59)
-- The United States ((29) -- Canada 6) -- Japan (2) -- Europe (21) -- France (1) -- Germany (6) -- The United Kingdom (2) -- Spain (1) -- Rest of Europe (11) -- Asia-Pacific (Excluding Japan) (1)
For more information about this report visit https://www.researchandmarkets.com/research/jlt734/global_digital?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets